UNCY

UNCY

Unicycive Therapeutics Inc. Common Stock

$0.638+0.000 (0.000%)

即時價格

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$0.638

最高

$0.638

最低

$0.638

交易量

4.18M

公司基本面

交易統計

相關新聞

GlobeNewswire

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,

查看更多
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Analyst Upgrades

HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.

查看更多
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
GlobeNewswire

Unicycive Therapeutics to Present at Upcoming Investor Conferences

LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh

查看更多
Unicycive Therapeutics to Present at Upcoming Investor Conferences